Conduct Phase III CT: CDSCO Panel Tells Zydus Healthcare on Glycopyrrolatem plus Indacaterol metered dose inhalation Dr. Divya Colin24 Nov 2024 5:30 PM ISTNew Delhi: Considering the bioequivalence study report presented by Zydus Healthcare, the Subject Expert Committee (SEC) functional under the Central...
Zydus Healthcare Gets CDSCO panel Nod To Market Vilanterol, Glycopyrrolate FDC metered dose inhalation Dr. Divya Colin23 Nov 2023 6:00 PM ISTNew Delhi: The drug major Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
GSK to start phase 3 trials of low-carbon Ventolin inhaler in 2024 Ruchika Sharma23 Nov 2023 3:26 PM ISTLondon: GSK plc has announced it will start Phase III trials of a low carbon version of its metered dose inhaler (MDI), Ventolin (salbutamol), using a...
Zydus Healthcare Gets CDSCO Panel Nod to study Fluticasone, Glycopyrronium, Vilanterol FDC metered dose inhalation Dr. Divya Colin19 Sept 2023 6:00 PM ISTNew Delhi: The drug major Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
NPPA panel fixes retail price of Zydus healthcare's Glycopyrrolate, Formoterol,Budesonide metered-dose inhaler Dr. Divya Colin27 March 2022 12:30 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of Glycopyrrolate, Formoterol, and Budesonide...
